![CDER Small Business and Industry Assistance Webinars www.fda.gov/CDERSBIALearn](https://public4.pagefreezer.com:443/content/FDA/01-05-2023T13:41/http://www.fda.gov/files/styles/medium_3/public/New_SBIA_WebinarSeries_1600x900_211109_1308.png?itok=RsBZrdcn)
FDA to discuss guidance on labeling for prescription drugs and biologics
March 30 - Discussion will focus on the dosage and administration section
March 30 - Discussion will focus on the dosage and administration section
March 29 - Group aims to advance development of lupus treatments
March 28 - Event will address challenges in trial design and analysis
March 24 - For adult and pediatric patients 12 years of age and older
March 21 - New materials answer patient questions about biosimilars treatment options
March 15 - Topics will focus on ANDA submissions, GDUFA III, IT updates and more
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.